ArticleFrontiers in cardiovascular medicine2026

Proactive, short-term PCSK9 inhibition after PCI in patients with coronary artery disease at high residual risk: rationale and design of the randomized HANYANG-PICK trial.

Woohyeun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.